Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to tea42,yyuryyub,Howyoudoin,Anonymous,EverybodyKnows, for Donating to support the site

MrC's Smallcap Sweeps for Jun 2022

Discuss Stock buying Shares, tips and ideas for stock market dealing
MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

MrC's Smallcap Sweeps for Jun 2022

#504145

Postby MrContrarian » June 1st, 2022, 7:42 am

Smallcap Sweep. 01-Jun-22
MEAL delivers another choker

Nanosynth (NNN) gives up on manufacturing antiviral masks. Stock written off. strategic review has identified seven new verticals in which the Company intends to focus on licensing its nanoparticle technology. [SP=0.41 Cap=8m]
Dewhurst (DWHT) was hacked on 23 May. "Manufacturing facilities have remained operational and continue to service the demands of its customers at most sites, but administrative systems are not currently fully operational. The remediation process at the Company's sites is underway and individual sites are likely to come back gradually over a period of time...Board expects the impact to the underlying trading of the business to minimal with revenues expected to remain broadly in line with market expectations...but profitability of the Company for FY22 to be materially below expectations." [SP=1400 Cap=81m]
Novacyt (NCYT) UK approval of PROmate COVID-19 1G (q16) Real-Time PCR test. Also PathFlow COVID-19 Rapid Antigen Self-Test has received a CE mark. [SP=153.85 Cap=130m]
Orchard Funding (ORCH) guides FY(July) posttax 25% above expectations (whose?). [SP=52.39 Cap=11m]
Harland & Wolff (HARL) wins initial contract worth c. £8.5m for the fabrication of eleven barges. Build end around Q2 2023. [SP=13 Cap=21m]
Open Orphan (ORPH) wins £14.7m contract for flu study and a follow on human challenge study. Rev booked across 2022 and 2023. [SP=14.9 Cap=100m]
Parsley Box (MEAL) recent 5 months rev 11% behind expectations although adj EBITDA loss is circa 10% better than management expectations. Guides FY rev c.£22.5m. Blames reduction in consumer confidence. "Our excellent value ambient meal range is well suited to allow us to hedge short term inflation pressure and we hope this will help alleviate pressure on our customers' wallet." Or they could just buy ready meals from Tesco and Aldi. [SP=18.73 Cap=14m]
Location Sciences (LSAI) strategic update - board continues to explore various options for acquisition candidates, war makes it more challenging than anticipated. [SP=0.25 Cap=7m]
Feedback (FDBK) guides FY(May) rev materially ahead of market expectations due to good Bleepa sales and additional technology license fees. [SP=0.63 Cap=17m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

read it first on Twitter

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#505188

Postby MrContrarian » June 6th, 2022, 7:39 am

Smallcap Sweep. 06-Jun-22
To sleep, perchance to dream that EVE is viable

Supply @ME Capital (SYME) appoints new chair. Last one left in March after 5 months. They should get a plastic garden chair, it would last longer. [SP=0.08 Cap=31m]
MGC Pharmaceuticals (MXC) CogniCann success in Phase II trial. Trial results demonstrate the ability to inhibit the deterioration in the behaviour (not cognitive ability) of patients with Dementia. [SP=1.11 Cap=57m]
eve Sleep (EVE) hoists For Sale sign. Orders in recent 5 months down 15% in UK and 3% in France but outperformed the markets. Expetcs FY miss on rev, gross margin and cash balance. [SP=1.67 Cap=5m]
Brave Bison (BBSN) wins £1.7m of contracts, delivery in the next six to nine months. [SP=1.7 Cap=18m]
Abingdon Health (ABDX) sells 10 million Abingdon Simply Test COVID-19 antigen tests to Taiwan, subject to receiving Taiwan Emergency Use Authorization. [SP=11.35 Cap=14m]
ADVFN (AFN) returns to disappointng, with H2 rev below H1 and significantly down yoy. Cash down to £900k. Suspends divs. [SP=77.99 Cap=21m]
Tungsten (TUNG) Pagero win't hike 48p offer. Kofax offering 55p. [SP=57 Cap=72m]
Nanoco (NANO) wins 'major' 1 yr work package from its important European electronics customer. "The contract delivers a monthly revenue run rate equivalent to that delivered in H1 FY22 " [SP=38.5 Cap=118m]
Gfinity (GFIN) extends relationship with Formula 1 for a year to deliver the main elements of the F1 Esports Series in 2022. [SP=1.12 Cap=14m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#505491

Postby MrContrarian » June 7th, 2022, 7:34 am

Smallcap Sweep. 07-Jun-22
Culling overpopulation in morning missives

Downing Renewables & Infrastructure (DORE) £50m placing & OO at 111p, a 1% discount, to cut debt and buy assets. [SP=113.8 Cap=156m]
Ted Baker (TED) preferred bidder pulls out, says not linked to its due diligence. Will talk to other bidders. [SP=136.8 Cap=253m]
Filtronic (FTC) $0.9m follow-on contract for full production units after a successful pilot-phase with US customer. Recognised in FY2023. [SP=9.8 Cap=21m]
Argo Blockchain (ARB) mined only 124 Bitcoin Equivalents in May vs 166 in Apr. Blames things. Rev £3.07m (Apr: £5.52m). [SP=52 Cap=244m]
Photo-Me (PHTM) guides H1(Apr) rev up 24%, above expectations (whose?). Trading has now returned to pre-pandemic levels across all markets bar Asia. Guides FY rev up 20%+ and pretax £47-50m. [SP=70.6 Cap=267m]
Haydale Graphene (HAYD) guides FY(June) rev ahead of market expectations. Cites strong launch of Hi-Therm, sales of functionalised boron nitride conductive fluids. However slow sales of silicon carbide to East Asia. [SP=6.5 Cap=33m]
Capita (CPI) 3 yr extension to Primary Care Support England contract. [SP=25.46 Cap=429m]
Vertu Motors (VTU) extends buyback by up to £3m. [SP=56.4 Cap=200m]
Parsley Box (MEAL) CEO buys £18k of shares. Goes to show there's still a market for overpriced crap. [SP=18.7 Cap=14m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#505688

Postby MrContrarian » June 8th, 2022, 7:44 am

Smallcap Sweep. 08-Jun-22
Summary execution

Journeo (JNEO) wins contracts worth £1.7m over 5 yrs from Nottingham city. Expects to book £0.5m this FY. [SP=114.7 Cap=10m]
Scholium (SCHO) FY(Mar) trading: continued to trade profitably in H2. Er, in line? Will close Mayfair Philatelics business. Why? What a rubbish RNS. [SP=40.05 Cap=6m]
1Spatial (SPA) £0.9m contract from HS2. Potential options to extend for a further two years. [SP=50.28 Cap=56m]
Xeros Technology (XSG) Xeros enabled domestic washing machine launch delayed from Q3 to now planned for Q4 2022. [SP=32.12 Cap=8m]
Coral Product (CRU) guides FY rev £14.4m+ (£10.7m). Pretax still expected to be materially above market expectations, as announced in Apr. Final div 0.2p making 1.1p total, up 10%. [SP=17 Cap=14m]
Marks Electrical (MRK) FY(Mar) rev up 44% in line with trading stmt. Current FY rev up only 20% but says this is "continued positive trading momentum...Disciplined approach to margin management, capital allocation and cash conversion demonstrated in FY22, provides the Group with solid foundations to deliver our financial targets and strategic objectives in the year ahead." [SP=91.48 Cap=96m]
STM (STM) delayed FY(Dec) out. "Whilst our existing recurring revenue has held up well, it has been frustrating that the significant amount of work and change occurring in the background has not yet resulted in the improved margins or new business growth anticipated." CFO resigns. She is thanked. Outlook "well positioned to take advantage of all the hard work and initiatives that we have undertaken...confident this will lead to an increase in our unadjusted operating margins, so that we will be more comparable to our peers. In the short term, this may result in increased costs as we redeploy our resources....We do not expect [the war] to have a material impact on the Group's operations." [SP=26.9 Cap=15m]

In line: SFE, CPC, FUL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#505983

Postby MrContrarian » June 9th, 2022, 7:39 am

Smallcap Sweep. 09-Jun-22
Free summaries worth every penny

R.E.A. (RE.) AGM stmt: "With current CPO and coal prices, notwithstanding some inflation in costs, the group is enjoying good cash flows." [SP=156.9 Cap=69m]
AO World (AO.) review of German biz: will close it. c.10% of group rev. Closure will incur cash costs of nil to £15m. Trading in line. [SP=74.25 Cap=356m]
Xpediator (XPD) AGM stmt: co continued to trade well with impact from the war largely offset with increased volumes in other markets. "The Group is in a good position, and with its asset light base, it is shielded from some energy and other inflationary cost pressures, but not all." [SP=36 Cap=51m]
DFS Furniture (DFS) Q4 to date order volumes down c2% on pre-pandemic. Supply-chain disruption and lower order intake since April has led to lower levels of production and deliveries relative to expectations. Guides FY rev £1,150-1,160m and U/L pretax £57-£62m. Order bank c. 2.5% of rev relative to pre-pandemic level. Expects YE net debt <£100m, in line with the upper end of 0.5x-1.0x target leverage. [SP=185 Cap=476m]
Sopheon (SPE) AGM stmt: closed six (all SaaS) new customer wins - compared to ten in the whole of 2021. ARR $21.7m ($19m). [SP=558.5 Cap=59m]
Northbridge Industrial Services (NBI) trading ahead of upgraded expectations. [SP=190 Cap=53m]
Hargreaves Services (HSP) guides FY (May) ahead of market expectations, due to the continued strong performance of JV in Germany which will contribute £3.5m post-tax more than estimates. [SP=562.87 Cap=183m]
Norcros (NXR) FY(Mar) rev as guided. Adj EPS 38.2p up 23%. Current trading in line. [SP=242 Cap=216m]
Peel Hunt (PEEL) FY(Mar). Outlook: "Market conditions were challenging in the second half of FY22, particularly in the last quarter where exceptionally low levels of capital markets activity were experienced market wide. We expect ECM activity to continue in line with Q4 of FY22 through the first half of FY23." [SP=116.02 Cap=142m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#506210

Postby MrContrarian » June 10th, 2022, 7:35 am

Smallcap Sweep. 10-Jun-22
Hey what's cooking? A warning, that's what.

ProCook (PROC) another recent IPO smacks its holders in the face. Warns FY23 rev broadly in line with FY22 (£69.2m) and adj pretax £4-6m. Blames the 'difficult consumer backdrop'. Or maybe the lockdown home cooking boom wasn't going to last. [SP=78 Cap=85m]
Renalytix (RENX) study shows "increased adherence to care guidelines for physicians using KidneyIntelX risk assessment to improve outcomes, alleviate patient suffering...in rapidly progressing chronic kidney disease". KidneyIntelX is available clinically as a laboratory developed test. [SP=183 Cap=161m]
Origin Enterprises (OGN) guides FY22 adj EPS 64 to 68c. Cites strong trading in Q3-4. "High crop prices continue to support strong on-farm sentiment, with crop establishment and weather conditions generally favourable across all three segments...offset by reduced fertiliser demand due to significantly higher raw material costs." [SP=4.38 Cap=NA]
Light Science Technologies (LST) another recent IPO warns FY(Nov) rev 35% below market expectations and a £2m loss. Blames elongation of the sales cycle due to government grant delays and input inflation for growers. Order book £18m. [SP=11.85 Cap=NA]
Netcall (NET) wins 3 yr $19m contract for the Liberty platform with a S&P 500 international financial services firm. [SP=66.5 Cap=100m]
M.P. Evans (MPE) AGM stmt: production flat but average price of CPO for the first five months was $1,630/T up 45%. Total FY dividend 35p. [SP=972 Cap=529m]
Mind Gym (MIND) FY(Mar) in line. Outlook: FY23 expected to return to profitability as investments in FY22 produce results. [SP=117.9 Cap=118m]

In line: ERGO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#506778

Postby MrContrarian » June 13th, 2022, 7:42 am

Smallcap Sweep. 13-Jun-22
Cuts of investor meat

Devolver Digital (DEVO) cuts FY22 rev range to $130-140m (up 30%) due to "a competitive release window and specific factors for each title which are being actively addressed for future titles". Adj EBITDA $27-32m up c.15%. [SP=138 Cap=612m]
Randall & Quilter (RQIH) $100m+ placing and OO at 105p, a 14% premium! [SP=92.69 Cap=256m]
Aptamer (APTA) CFO resigns 'for personal reasons' but will stay at NED until Dec. She is thanked. [SP=98.7 Cap=67m]
Gateley (GTLY) guides FY(Apr) rev up c.13% and pretax up c.10%+, ahead of market expectations. Cites continuing strength of the UK M&A and Private Equity markets. Current FY in line. [SP=211 Cap=264m]
Diaceutics (DXRX) $2m+ 3 yr contract with a top five global pharma company to deliver customised data insights. [SP=105 Cap=89m]
N4 Pharma (N4P) Medicines Discovery Catapult study shows demonstrable suppression of tumour growth using a reduced load of TNFalpha with Nuvec. And other progress. Co "very pleased with recent results across oncology, the potential opening up of the siRNA market and the early data coming from UQ on their oral work". [SP=2.6 Cap=5m]
Spectra Systems (SPSY) again fails to get enough shareholder votes to achieve a quorum for an AGM. [SP=139.75 Cap=63m]
Proton Motor Power Systems (PPS) hikes loan facilities with SFN Cleantech Investment and Falih Nahab in order to satisfy its working capital needs until at least June 2023. "However it does not currently expect to generate net free cash by that time and therefore may require additional funding for its future working capital needs." [SP=10.67 Cap=161m]
Tekmar (TGP) hoists for sale flag 'cos it "may not have the necessary cash to make all the required investment to deliver fully the turnaround strategy to return the Group to profitable cash generation within the timescale targeted by the Board." Not currently in discussions with, nor in receipt of an approach. [SP=39.75 Cap=24m]

In line: TGP, SOM
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#507037

Postby MrContrarian » June 14th, 2022, 7:40 am

Smallcap Sweep. 14-Jun-22
Parting the red sea

Vela Technologies (VELA) gerrible screw up: its broker bought £300k of shares in a TruSpine placing w/o the board's approval. Co considering whether to keep the shares since it was considering such an investment. [SP=0.03 Cap=5m]
Palace Capital (PCA) CEO scarpers. He is thanked. IIs this connected to the strategic review to close the discount to NAV? FY results. Outlook "likely to be further affected by continuing macroeconomic and geo-political uncertainty, particularly arising from the continuing war in Ukraine. The inflationary headwinds and the consequential impact on consumer and investor confidence are likely to constrain UK economic growth in the short term". [SP=269 Cap=125m]
Ten Lifestyle (TENG) contract wins, incorporated within existing growth plan and expected to launch by the end of this FY. [SP=61.28 Cap=51m]
Open Orphan (ORPH) £7.2m contract with an existing top 5 global pharmaceutical company to test its orally administered antiviral product. [SP=12.05 Cap=81m]
HeiQ (HEIQ) a study found that European hospitals could save €760m PA in medical costs related to healthcare-associated infection. through switching to probiotic cleaning products such as HeiQ Synbio from traditional disinfectants. HeiQ relaunched the extended Synbio range at Interclean Amsterdam. [SP=97 Cap=132m]
MyHealthChecked (MHC) launches five new at-home cheek swab DNA 'wellness' tests. Cost £54 each and cover Intolerances & Sensitivities, Weight Management and so on. "These initial tests are just the start of our consumer testing portfolio." [SP=1.65 Cap=13m]
Revolution Bars (RBG) guides FY adj EBITDA (after rental charges on an IAS 17 basis) slightly ahead of the top end of market expectations of £10m. Cites Jubilee Bank Holiday boost. [SP=14.96 Cap=34m]
GAW guides FY(May) core revenue to be not less than £385 million (2020/21: £353 million) and royalties receivable of £28 million (2020/21: £16 million). The Group's profit before tax is estimated to be not less than £155 million (2020/21: £151 million). [SP=NA Cap=NA]
IXICO (IXI) £0.8m four yr contract extension. [SP=36.25 Cap=17m]

In line: AFRN, SNX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#507302

Postby MrContrarian » June 15th, 2022, 7:41 am

Smallcap Sweep. 15-Jun-22
Shooting arrows at moving targets

Immediate Acquisition (IME) suspended pending approval of RTO of of Fiinu Holdings. Placing yesterday to fund it. [SP=20 Cap=8m]
Spectra Systems (SPSY) extends a central bank contract ,increasing the sensor development phase revenues by $2m. [SP=134.99 Cap=62m]
Redx Pharma (REDX) JZP815 to enter clinical development and triggers USD $5m milestone payment. JZP815 is a drug candidate for several types of difficult-to-treat solid tumours. [SP=60.8 Cap=203m]
Dillistone (DSG) AGM stmt: all products performing broadly in line with, or better than, expected. Nevertheless says FY in line with market expectations. [SP=20 Cap=4m]
T42 IOT Tracking Solution (TRAC) initial order for 500 units for t42's sensor fusion based tracking solutions and cloud platform services in Latin America. No $$$. [SP=11.28 Cap=6m]
Saietta (SED) to sell fully integrated e-drive systems sooner than planned, to capture vertically integrated margins as opposed to focusing on standalone motor sales. "This is expected to materially enhance Saietta's jam tomorrow." Excitable language in spades. [SP=141 Cap=120m]
SourceBio International (SBI) AGM stmt: sounds in line. [SP=120.55 Cap=89m]
Dewhurst (DWHT) H1(Mar) broadly in line with market expectations. Rev down 6%, pretax up 11%. "Transport sales were significantly down compared to the previous year, which had been supported by a number of Government Cycle Projects." Margin pressure due to higher costs. Cyber attack disruption to ops expected to continue through June. Guides FY profit below last year and below market expectations. [SP=1215 Cap=69m]
Castings (CGS) FY(Mar). Outlook: higher costs but better demand. It's "expected that costs will continue to increase...including significant electricity rises when our current fixed contract comes to an end on 30 September. Our customers have been made aware of the situation and the fact that, in order to continue to supply, the cost increases will be passed on...Our customers are now increasing their demand and, in this respect, they are more successfully managing the supply of semiconductors and other items in the supply chain. It is hoped that this will continue so we can enjoy improved sales in the current financial year." [SP=282 Cap=123m]

In line: NAH, SFR
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

SwissPaul
Lemon Pip
Posts: 92
Joined: November 6th, 2016, 7:12 pm
Has thanked: 27 times
Been thanked: 28 times

Re: MrC's Smallcap Sweeps for Jun 2022

#507460

Postby SwissPaul » June 15th, 2022, 6:33 pm

Mr C, as always a big thanks for the daily sweep.

You missed a biggy though!
DX (Group) PLC
14 June 2022
DX is pleased to announce that PKF Littlejohn LLP ("PKF") has been appointed as the Company's new auditor, with the appointment taking effect immediately.

Yippeee - this will be interesting in this long saga and I think all holders just want this bottomed out.

Good Luck all

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#507542

Postby MrContrarian » June 16th, 2022, 7:46 am

Smallcap Sweep. 16-Jun-22
Squeezing news juice from city plumbs

Best of the Best (BOTB) tender for c.11% of shares at 600p, a 52% premium. [SP=394 Cap=37m]
ASOS (ASC) cuts FY guidance: rev growth only 4% to 7% and adj pretax £20m to £60m. Blames high return rate in UK & Europe due to belt tightening. Also new CEO and NED become chmn. [SP=1139.7 Cap=1139m]
Seeing Machines (SEE) appointed by an existing global automotive customer to deliver its FOVIO Driver Monitoring System for a large global automotive group (OEM). A$23m initial value with production scheduled from mid-2024. To target safe level 2-3 semi-autonomous driving and expected regulation. [SP=7.1 Cap=294m]
Feedback (RDBK) put numbers on its recent 'materially ahead of market expectations' trading stmt. Guides FY rev up 105% (but still only £0.59m). Outlook - "The Company's growing portfolio of clinical communications apps and strong growth trajectory underpin management's confidence." [SP=NA Cap=NA]
musicMagpie (MMAG) guides H1(May) rev down 2% but Consumer Technology products up 16%. Disk Media and Books fell 24%. "Consumer Technology has been intentionally tempered by promoting our contracted monthly rental subscription service over outright purchase." Adj EBITDA £2.6m (£6.2m). [SP=51.25 Cap=55m]
Novacyt (NCYT) makes counterclaim as expected of £81.5m against the DHSC in its covid test dispute. [SP=140 Cap=116m]
Cizzle Biotechnology (CIZ) Behnke to promote, identify and facilitate partnerships for Cizzle with healthcare providers and businesses in the USA. [SP=1.71 Cap=5m]
Immotion (IMMO) three-year licensing deal for virtual reality experiences in the Chinese Aquarium market. [SP=3.81 Cap=16m]
Genedrive (GDR) NICE to evaluate MT-RNR1 test via its Diagnostics Assessment Programme. [SP=20.5 Cap=19m]
Anpario (ANP) AGM stmt: recent 5 months rev are just ahead YoY "which we consider a good performance given China's recent Covid lockdown and the war". "We expect the challenging environment to continue until the end of the year." [SP=595 Cap=142m]

In line: BOO, BWNG, ANX, NWF
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#507807

Postby MrContrarian » June 17th, 2022, 7:35 am

Smallcap Sweep. 17-Jun-22
Low-octane financial fuel

M&C Saatchi (SAA) volte face on Next 15 recommended offer - advises holders to vote against, due to the fall in Next 15's SP. [SP=177 Cap=216m]
Directa Plus (DCTA) AGM stmt. Rev growth accelerates to 44% in 5 months to end May. Co remains optimistic on its ability to secure a very material contract this FY. [SP=95.1 Cap=64m]
Christie (CTG) instructed to sell iconic UK visitor attraction, The Trentham Estate. Never heard of it. Rest of RNS reads as an advert for the venue, "an easily accessible location with 7.5m people living within an hours' drive-time". Ooh it has a shopping village and a Monkey Forest. Well, I have a farm shop with crocodiles and meercats near me, so beat that! [SP=122 Cap=32m]

In line: ACC
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#508406

Postby MrContrarian » June 20th, 2022, 7:44 am

Smallcap Sweep. 20-Jun-22
The Poundland premarket lens

SThree (STEM) guides FY(Nov) pretax at least 5% ahead of market consensus of £66.2m. Q2 net fees up 23%. "Demand from our clients for people with STEM skills, together with our strong contractor order book, underpins our confidence." [SP=322.83 Cap=432m]
CYBA (CYBA) will change name to NARF Industries following its RTO. [SP=1.7 Cap=29m]
Forward Partners (FWD) downward pressure on the valuations in its Ventures portfolio as tech stock prices fall and funding rounds taking longer. "The Ventures and Studio teams continue to work closely with the portfolio management teams to ensure that they are able to extend existing resources to trade through this period of uncertainty. Moreover, the Group expects to continue to find attractive new investment opportunities in what is becoming a more favourable climate for in-price valuations." [SP=55 Cap=80m]
Brighton Pier (PIER) changes FY accounting date from June to Dec,"as it ensures that the typically busy summer trading months are aggregated within a single reporting period". That's only just now occurred to them, a week before the year end? Trading in line. [SP=81.45 Cap=30m]
EKF Diagnostics (EKF) dividend in specie of investment in Verici Dx. [SP=33.4 Cap=152m]
Graft Polymer (GPL) Slovenian operation has recently reached cash flow positive status through organic growth of its production contracts. "We are very pleased that our suppliers have confirmed the delivery of this major equipment across both our Polymers and Bio divisions, enabling us to accelerate our research into these innovative and potentially sector-changing products." [SP=16.01 Cap=NA]
Rank (RNK) warns FY(June) LFL underlying operating profit c.£40m cf £47m-55m previously guided. Blames "slower than expected return of higher spending overseas customers to our London casinos, continued softness in visitor numbers across the UK and a lower-than-average casino win margin in the quarter to date". [SP=99.2 Cap=465m]
Filtronic (FTC) guides FY(May) rev £17.1m and adj EBITDA £2.7m+, both above market expectations despite the semiconductor shortage. Has significant repeat orders for delivery in FY2023. [SP=9.44 Cap=19m]
Plexus (POS) £500k order for for Plug and Abandonment equipment, recognised in calendar 2023. [SP=3.8 Cap=4m]
AFC Energy (AFC) Kier Group initial lease of Power Tower clean Hydrogen power generator units in H2 2022. It will "provide a basis for a longer-term collaboration with the aim of delivering additional fuel cell systems in 2023." [SP=24.56 Cap=180m]
Ilika (IKA) £105k grant for six-month economic feasibility study on creating a dedicated 100 MWh SSB manufacturing line at the UK Battery Industrialisation Centre. [SP=55.5 Cap=88m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#508582

Postby MrContrarian » June 21st, 2022, 7:45 am

Smallcap Sweep. 21-Jun-22
The full jerry-can of financial fuel

finnCap (FCAP) founder Sam Smith to step down in Autumn. [SP=20.95 Cap=38m]
Morses Club (MCL) ("It's not a club") increase in complaints submitted by claims management companies. if sustained, could hit H1 2023 trading performance. [SP=10 Cap=13m]
Van Elle (VANL) get on Piling framework for the West of Leeds section of the Transpennine Route Upgrade. [SP=38 Cap=41m]
Ensilica (ENSL) as expected, gets production schedule for more than 2.5m ASICs in a a new flagship car, over 12 months. The ASIC has an anticipated seven-year production life with up to 24 ASICs per vehicle. [SP=NA Cap=NA]
Tremor (TRMR) makes 'strategic' ('natch) $25m investment in VIDAA , a smart TV operating system and streaming platform. VIDAA is a subsidiary of major TV co Hisense. "We believe the Investment can support VIDAA's plan to increase its distribution across additional OEMs" [SP=357.4 Cap=548m]
K3 Capital (K3C) guides FY(May) comfortably ahead of market expectations with rev up c.43% (c.18% organic) and adj EBITDA up c.24% to c.£19.5m. Strong performance across all three business units. Outlook bullish. [SP=235 Cap=173m]
HSS Hire (HSS) AGM stmt: Q2 rev up 10%. In line? [SP=15.11 Cap=106m]
idatech Pharma (MTPH) gets Orphan drug status for MTX110 for the treatment of recurrent glioblastoma. "The designation is intended to offer a range of incentives that facilitate development of the medicine, such as protocol development assistance, reduction in fees and market exclusivity upon successful approval of the drug." [SP=8.69 Cap=9m]
Gaming Realms (GMR) wins Online Gaming license in Connecticut. Expects its Slingo content to go live in the state with operators by the end of 2022, [SP=23.48 Cap=69m]
Slingsby (SLNG) rev growth increases to 8% in Jan -May, from 4% in Jan-Mar. Offsets fall in gross profit margin. "The market remains competitive and the Group remains cautious." [SP=205 Cap=2m]
EQTEC (EQT) gets dent funding for 1MWe waste-to-energy project in Greece. [SP=0.66 Cap=56m]
Pelatro (PTRO) selected by a large global telco to provide its mViva Campaign Management Solution to provide a Proof of Concept. If successful, mViva will be rolled out progressively to all the opcos of the telco. Full potential of this recurring revenue contract would be about $4m PA starting 2023. [SP=27.1 Cap=12m]
FireAngel Safety Technology (FA.) AGM stmt: H1(June) in line. Gross margin is expected to improve more strongly in Q3. [SP=11 Cap=20m]
R.E.A. (RE.) Indonesian government new export levy scales: total tariffs are lower. [SP=154 Cap=68m]
M.P.Evans (MPE) see R.E.A. announcement re Indonesian tariffs. [SP=982 Cap=543m]

In line: SPA, G4M
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#508771

Postby MrContrarian » June 22nd, 2022, 7:44 am

Smallcap Sweep. 22-Jun-22
Own brand news tonic

NetScientific (NSCI) completes £1.5m placing at 67p, an 11% discount, to "exploit its prospects, attractive deal pipeline and market opportunities...". [SP=72.3 Cap=15m]
Impact Healthcare REIT (IHR) €8m placing ar 117p, a 5% discount, for aquisitions. [SP=122.6 Cap=473m]
Provexis (PXS) partner DSM Nutritional Products will transfer most of its Fruitflow customers and also facilitate the transfer of its outsourced supply chain / production process to PXS when the contract ends on Dec 31. PXS will pay sales royalty for 4 yrs. PXS files patent application "relating to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans". [SP=0.95 Cap=21m]
Celadon Pharmaceuticals (CEL) update on progress on the development and supply of natural, cannabis-based medicines. [SP=108 Cap=67m]
Angle (AGL) wins additional contract with its first large-scale pharma services customer. Parsortix system to be used in in a new Phase Ib dose-escalation study. Worth up to $1.2m over a multi-year period. [SP=93 Cap=219m]
Braime (BMTO) cost of chain cell project soars to £1.9m fro prev estimate of £850k. It's partly inflation but £870k extra is for an "opportunity, forced on us by the need to fully demolish and reconstruct this area, to also more than double the area available for the production of 4B Chain". [SP=1600 Cap=23m]
System1 (SYS1) to make buybacks and/or tender offers instead of resuming divs. Guides amount of 30 - 40% of through-the-cycle profit after tax. Also one-off £1.5m tender soon. [SP=272 Cap=35m]
Churchill China (CHH) AGM stmt: "Record demand has continued and our order book remains healthy. We remain confident in our ability to deliver an improved year on year performance in 2022." [SP=1400 Cap=154m]
Vertu Motors (VTU) AGM stmt: "strong start to the financial year but it is premature at this stage to indicate any changes to market expectations of the full year trading profits". Shortages of new and used cars continue. [SP=53.3 Cap=187m]
Bonhill (BONH) to sellBusiness Solutions & Governance division to focus on its core offering. Guides H1 rev up 9% but with lower gross margin. Guides EBITDA loss flat. [SP=5.67 Cap=7m]

In line: SKL, IUG, TEAM
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#508947

Postby MrContrarian » June 23rd, 2022, 7:51 am

Smallcap Sweep. 23-Jun-22
Tandem cycling highly cyclic

Bango (BGO) agreement with global technology leader to use Bango Platform to provide carrier billing and bundling services for its app store payments and subscription services. Will not benefit Fy22 but "will continue to review the potential impact in FY23 and beyond, as the relationship develops". [SP=126.5 Cap=96m]
Tandem (TND) AGM stmt: last 24 weeks has remained challenging with rev 31% down. Last 7 weeks up 8% though. Bike div rev down 55%, eMobility down 26%. Home & Garden rev down 56%. Final div 6.57p. Outlook challenging with order book only £10m (£35.4m). [SP=300 Cap=16m]
Fonix Mobile (FNX) secondary placing of at least 6.7m shares at 150p, a 4.4% discount, "to satisfy strong institutional demand". Sale is by directors, shareholders and employees. [SP=157 Cap=157m]
Scancell (SCLP) will develop GlyMab antibodies into T cell redirecting bispecific (TCB) antibodies. "This is a promising new therapeutic approach to treat cancer." [SP=14.13 Cap=115m]
Engage XR (EXR) wins £300k 3 yr contract. Also HTC, and The Virtual Human Interaction Lab at Stanford University are confirmed as launch partners for Metaverse offering for enterprises - "ENGAGE Link" - expected in Q4. The partners will have plazas in the metaverse. [SP=12.11 Cap=35m]
MTI Wireless Edge (MWE) wins €1m of orders in Italy for delivery in Q3 2022. [SP=61 Cap=54m]
Galliford Try (GFRD) appointed to the new Midlands Highways Alliance Plus Medium Schemes Framework 4. Framework is £1bn over 4 yrs. CO has been a main contractor with the MHA+ since 2014. [SP=174.89 Cap=194m]
Next Fifteen Communications (NFC) adj pretax YTD remains ahead of management expectations. Rev in Feb-Apr up 68% and 37% organic. Strong $ has helped. [SP=890 Cap=874m]
Manolete (MANO) FY(Mar) poor as expected. Outlook "As we return to more usual trading conditions, I am pleased to report that we are seeing strong growth in new case enquiries." [SP=298 Cap=130m]
First Property (FPO) FY(Mar) pretax £7.1m (-£5.9m). NAV £44m inc £6m cash. Outlook "The investment environment is volatile at present but with adversity comes opportunity and we are seeing some interesting market movements. Occupational demand is picking up from the lockdown induced lows which should result in a commensurate increase in the value of our properties." [SP=30 Cap=33m]
Supply @ME Capital (SYME) TradeFlow Capital Management subs has completed the first warehoused commodities monetisation transaction introduced by CARGOES Finance By DP World. [SP=0.07 Cap=30m]

In line: OMG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#509146

Postby MrContrarian » June 24th, 2022, 7:34 am

Smallcap Sweep. 24-Jun-22
Doctor, we're losing him!

Lamprell (LAM) possible cash offer but "at a very significant discount to the prevailing share price and any acceptable offer would need to include an interim funding solution or bridge financing." Co desparately needs $75m funding within two months. Talks have lasted two months but have not reached agreement on the price or conditions. eperate trading and funding update. Market strengthening but "current Group performance continues to be affected by the delivery of legacy, low margin projects and insufficient revenue levels as the Group emerges from a prolonged period of low market activity due to the low energy prices and more latterly, the impact of Covid". [SP=22.1 Cap=91m]
Trackwise Designs (TWD) guides FY(Dec '22) rev below market expectations but adj pretax in line. Blames reduced near term UK EV OEM customer demand. First 5 months of FY rev down 20%. Improved Harness Technology sales pipeline is 95 customers. [SP=59.2 Cap=22m]
MGC Pharmaceuticals (MXC) progress report including plan for commencement of a US Clinical Trial for CimetrA. [SP=0.91 Cap=39m]
Triple Point Energy Efficiency Infrastructure Company (TEEC) consulting on broadening the scope of the investment mandate to reflect the wider energy transition sector. Name change to Triple Point Energy Transition (TENT). That's a 33% saving in naming efficiency right there. [SP=89.37 Cap=89m]
RPS (RSP) Jan-May ahead of the mgmt expectations with rev (at const FX) up 12% and 100bp better margin. "although market drivers remain positive in North America, as reported in our Q1 update on April 27th, private equity activity has been slow in the first five months and delays continue in the initiation of government infrastructure projects, although we are starting to see improvements in the speed of project initiation." Expects momentum to continue in H2. [SP=NA Cap=NA]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#509912

Postby MrContrarian » June 27th, 2022, 7:49 am

Smallcap Sweep. 27-Jun-22
Begging for beats on the smallcap streets

Verditek's (VDTK) appointed exclusive supplier of lightweight solar panels to the JV between its distribution partner Bradclad and Protan AB. Also gets first order in Single Ply Membrane Roof market segment. No £££. [SP=1.8 Cap=6m]
Genflow Biosciences (GENF) agreement with Magnitude Biosciences, a specialist biotechnology research organisation that supports drug discovery and product development. This "will accelerate Genflow's future therapeutic developments and puts the Company on track to carry out its research and pre-clinical drug discovery". [SP=2.62 Cap=8m]
CareTech (CTH) reaches agreement with Amalfi Bidco on an offer of 750p, a 23% premium. [SP=612 Cap=694m]
Taylor Maritime Investments (TMIP) sells vessel for $17.2m. Cancels sale of another vessel agreed in March with the same buyer since the value has gone up. Trading: co "has covered 53% of remaining fleet days for the Financial Year ending 31 March 2023 at an average net TC rate of $19,700 per day. This provides strong earnings visibility and certainty, with the opportunity in this good market, to secure more charters at attractive rates for the remaining open days for the fleet." [SP=102.25 Cap=416m]
Immupharma (IMM) US partner Avion seeks final regulatory guidance as it prepares for the start of the international Phase 3 trial of Lupuzor in Lupus patients. "This final step by Avion is a pivotal moment for the Company." [SP=5.98 Cap=18m]
Symphony Environmental Technologies (SYM) Peru confirms d2w is not an oxo-degradable plastic, and does not generate microplastics. "This legal outcome has significant implications for Symphony's commercial growth in Peru and in Latin America generally." [SP=15.4 Cap=27m]
Inspirit Energy (INSP) Waste Heat recovery system unit has provided the highest recorded output of over 30kW in the first stage build test period. Sourcing materials and components has been challenging. "his is truly ground breaking technology and the application can be applied to marine, waste heat recycling from energy generation, refrigerated transport that uses diesel engines and many more applications." [SP=0.03 Cap=1m]
Hyve (HYVE) H1 momentum continued into Q3, full recovery for the remaining biz following sale of Russian biz. Forward FY bookings are £122.3m excluding £6.5m for the August Chinese events. Continued uncertainty around running events in China. [SP=68 Cap=198m]
Belluscura (BELL) launch of its Bluetooth enabled, next generation X-PLOR portable oxygen concentrator (previously described as the X-PLOR CX). It provides more oxygen by weight than any portable oxygen concentrator in its class. [SP=86.2 Cap=101m]
Northern Bear (NTBR) guides FY(Mar) adj op profit £2.5-2.6m after strong H2, despite ongoing headwinds. [SP=58.6 Cap=11m]
Keller (KLR) trading in line. Wins major contract for NEOM Giga project in Saudi Arabia. [SP=700 Cap=509m]
Nuformix (NFX) initiates further studies as it continues to generate a robust pre-clinical data package to support the progression of NXP002, a a potential novel inhaled treatment for Idiopathic Pulmonary Fibrosis. "These studies will directly address issues faced in the duration of action studies." [SP=0.33 Cap=3m]
CyanConnode (CYAN) gets follow-on order of 200k units from IntelliSmart Infrastructure for the smart metering deployment in Assam, India. [SP=14.13 Cap=34m]
Poolbeg Pharma (POLB) has completed the build and optimisation of a tailored AI model of Poolbeg's Respiratory Syncytial Virus human challenge data and will commence its analysis, with results expected in Q4 2022. [SP=5.84 Cap=NA]
Warpaint London (W7L) guides H1 rev over £24m up 30%, ahead of mgmt expectations at the start of the year. Gross margin is up. Outlook confident. [SP=108.35 Cap=83m]
Tavistock (TAVI) sounds in line. H1 div 0.07p, up 40%. [SP=7.17 Cap=40m]
Wise (WISE) FCA has commenced an investigation regarding the regulatory obligations and standards to which the CEO is subject. Follows his penalty for his deliberate default regarding their tax affairs. "After reviewing the matter late last year the Board required that [CEO] Kristo take remedial actions, including appointing professional tax advisors to ensure his personal tax matters are appropriately managed. The Board has also shared details of its own findings, assessment and actions with the FCA..." [SP=378.03 Cap=3873m]

In line: PTRO, SUN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#510144

Postby MrContrarian » June 28th, 2022, 7:50 am

Smallcap Sweep. 28-Jun-22
Cutting into the bone of BS

Symphony Environmental Technologies (SYM) supply agreement for its d2p antimicrobial technology with Grupo Bimbo, for its manufacturers. Co will supply d2p antimicrobial masterbatch to their nominated bread packaging manufacturers across the Americas. [SP=16.15 Cap=29m]
DeepMatter (DMTR) buys ChemIntelligence, a co with AI used to develop chemical products and reactions faster. Price up to £0.42m. [SP=0.11 Cap=5m]
Metro Bank (MTRO) PRA has reduced the Bank's Pillar 2A capital requirement from 1.11% to 0.50%. Also some change to its MREL (what's that?). [SP=77.5 Cap=134m]
M&C Saatchi (SAA) issues defence circular in response to the offer by AdvancedAdvT. [SP=159 Cap=194m]
GETECH (GTC) £1.65m 5 yr geospatial services contract 'significantly expands order book'. [SP=23.3 Cap=16m]
Tribal (TRB) guides FY(Dec) rev marginally ahead of mgmt expectations and EBITDA broadly in line. H1 EBITDA will be lower than the prior year due primarily to increased costs associated with a major customer implementation. EBITDA performance is expected to recover through H2. Also wins 3 contacts worth £5m over 3-5 yrs. [SP=89.5 Cap=188m]
Creo Medical (CREO) AGM stmt: momentum from 2021 has carried over with strong trading YTD. In line? [SP=91.08 Cap=165m]
Amigo (AMGO) plans new lending proposition under different brand, RewardRate, subject to FCA allowing a return to lending. "RewardRate aims to offer more affordable, responsible and flexible finance for underserved consumers who currently have few borrowing options. RewardRate also seeks to provide a pathway out of higher cost finance to cheaper credit by enabling those who make their loan payments on time to reduce their APR..." Reminds me of rebranding Windscale as Sellafield. [SP=5.3 Cap=25m]
Purplebricks (PURP) delays FY results to start of Aug "to allow sufficient time to complete the audit, which this year has included additional procedures as a result of new processes and controls..." No change to guidance. [SP=14.7 Cap=45m]
WANdisco (WAND) wins largest ever contract, for $11.6m with a top ten global communications company.50% in advance. [SP=266 Cap=175m]
Supply @ME Capital (SYME) Strategic Alliance with VeChain Foundation to provide up to $10m of funding for inaugural Inventory Monetisation transactions. Proof-of-concept transaction will be executed by end of July, "The objective of the Agreement is to create a sustainable Web3 environment that will allow direct participation in the Inventory Monetisation journey combining traditional finance with the blockchain space." A Web3 blockchain journey! What's not to like? [SP=0.08 Cap=35m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1396
Joined: November 4th, 2016, 2:45 pm
Has thanked: 41 times
Been thanked: 1438 times

Re: MrC's Smallcap Sweeps for Jun 2022

#510503

Postby MrContrarian » June 29th, 2022, 8:05 am

Smallcap Sweep. 29-Jun-22


Crossword Cybersecurity (CCS) early-stage discussions are being held with a number of acquisition candidates. [SP=27.06 Cap=21m]
McBride (MCB) bank has waived the June covenant tests until 30 Sept. Co continues to explore and assess all avenues to maintain liquidity and create additional funding. Trading in line. [SP=16.33 Cap=28m]
PPHE Hotel (PPH) modest £1.7m max buyback. May resume divs. [SP=1475 Cap=628m]
Brave Bison (BBSN) trading ahead of management expectations. [SP=1.98 Cap=21m]
Rosslyn Data Technologies (RDT) guides FY(Apr) rev £5.9m (down 20%), in line with market expectations but EBITDA loss £3.2m-£3.4m (£1.3m) due to development work associated with modernisation taking longer than expected. Current pipeline is substantially higher YOY. Will divest non-core elements: Integritie and Langdon Systems acquisitions "which have limited crossover with the Group's core business or strategic rationale". Why on earth did you buy them then? [SP=1.91 Cap=7m]
Lookers (LOOK) hikes H1 U/L pretax £45m (£50.3m). Uncertain on vehicle availability and how inflation will affect demand and costs. [SP=74 Cap=290m]
Windar Photonics (WPHO) FY audit delayed so shares will be suspended July 1. Guides FY(Dec) rev down 50% primarily due to project delays being experienced in China. Pretax -€1m (-€1.3m). Vestas order deliver has c. three month delay. [SP=14.4 Cap=8m]
Trackwise Designs (TWD) finals for FY21 delayed to July but gets extension so shares will not be suspended. Expectations un changed. [SP=49.74 Cap=19m]
Safestay (SSTY) gets FY21 results reporting extension, to July. Guides rev £6.4m and gross profit £5.1m. Q1 2022 rev slightly ahead of management's prudent expectations but overall trading since the year end remains in line. [SP=14.5 Cap=9m]
Eden Research (EDEN) AGM stmt: "positive outlook for 2022, with an anticipated return to stronger year-on-year growth, despite some difficult conditions"> [SP=4.04 Cap=15m]
Shoe Zone (SHOE) hikes FY(Oct) adj pretax guidance to £8.5m+. Cites "strong margin improvements and cost savings, in particular as a result of rent reductions and good supply chain management". [SP=155 Cap=78m]
MTI Wireless Edge (MWE) orders worth $0.85m, to be delivered in 2022. [SP=62.9 Cap=56m]
Nuformix (NFX) has initiated a programme of work to progress the NXP004 programme. [SP=0.33 Cap=2m]
ATOME Energy (ATOM) back-slapping AGM stmt. [SP=98.9 Cap=32m]
D4T4 Solutions (D4T4) wins 2 contracts just over £1m. [SP=242.5 Cap=97m]
XP Factory (XPF) AGM stmt - sounds in line [SP=20 Cap=31m]

In line: LORD, OCTP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian


Return to “Stocks and Share Dealing Discussions”

Who is online

Users browsing this forum: No registered users and 4 guests